title: [Advances in basic and clinical research on hepatocellular carcinoma in 2016].
abstract: Hepatocellular carcinoma (HCC) is still one of common malignant cancers worldwide, with increasing incidence and mortality rates. Early diagnosis and effective treatment for HCC remain to be explored. This article introduces the research advances in the early specific diagnosis and effective therapies for HCC in 2016, such as molecular markers in the specific diagnosis and targeted therapy for HCC, main therapeutic regimens, robot-assisted liver resection, and no-touch radiofrequency ablation.
authors.affiliation: Affiliated Hospital of Nantong University, Nantong Jiangsu Province 226001, China.
authors.forename: Z Z
authors.initials: ZZ
authors.lastname: Dong
authors.affiliation: Department of Liver Surgery, Liver Cancer Institute, Zhongshan Hospital, Fudan University, Shanghai 200032, China.
authors.forename: X D
authors.initials: XD
authors.lastname: Zhu
authors.affiliation: Department of Hepatobiliary Surgery, Key Laboratory of Liver Cirrhosis and Cancer in Beijing, People's Hospital, Peking University, Beijing 100044, China.
authors.forename: Z
authors.initials: Z
authors.lastname: Li
authors.affiliation: Department of Hepatobiliary Surgery, Key Laboratory of Liver Cirrhosis and Cancer in Beijing, People's Hospital, Peking University, Beijing 100044, China.
authors.forename: Y G
authors.initials: YG
authors.lastname: Mao
authors.affiliation: Institute of Hepatobiliary Surgery, Southwest Hospital, Third Military Medical University, Chongqing 400038, China.
authors.forename: Y L
authors.initials: YL
authors.lastname: Chai
authors.affiliation: Affiliated Hospital of Nantong University, Nantong Jiangsu Province 226001, China.
authors.forename: D F
authors.initials: DF
authors.lastname: Yao
authors.affiliation: Department of Liver Surgery, Liver Cancer Institute, Zhongshan Hospital, Fudan University, Shanghai 200032, China.
authors.forename: H C
authors.initials: HC
authors.lastname: Sun
authors.affiliation: Department of Hepatobiliary Surgery, Key Laboratory of Liver Cirrhosis and Cancer in Beijing, People's Hospital, Peking University, Beijing 100044, China.
authors.forename: J Y
authors.initials: JY
authors.lastname: Zhu
authors.affiliation: Institute of Hepatobiliary Surgery, Southwest Hospital, Third Military Medical University, Chongqing 400038, China.
authors.forename: K S
authors.initials: KS
authors.lastname: Ma
mesh_terms: D035843:Biomedical Research / Q000639:trends*; D006528:Carcinoma, Hepatocellular / Q000175:diagnosis* / Q000628:therapy*; D017115:Catheter Ablation; D006498:Hepatectomy; D006801:Humans; D008113:Liver Neoplasms / Q000175:diagnosis* / Q000628:therapy*
keywords: Carcinoma, hepatocellular; Diagnosis; Molecular marker; Radiofrequency ablation; Robert; Therapeutics